Public Profile

Zambon

Zambon S.p.A., a prominent player in the pharmaceutical and chemical industries, is headquartered in Italy. Founded in 1906, the company has established a strong presence in Europe, Asia, and Latin America, focusing on innovative solutions in healthcare. Zambon is renowned for its expertise in respiratory, pain management, and anti-infective therapies, offering unique products that address unmet medical needs. With a commitment to research and development, Zambon has achieved significant milestones, including the introduction of several patented formulations. The company is recognised for its high-quality standards and has garnered a solid market position, making it a trusted partner in the global healthcare landscape. Through its dedication to innovation and patient care, Zambon continues to make a meaningful impact in the pharmaceutical sector.

DitchCarbon Score

How does Zambon's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Zambon's score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

Let us know if this data was useful to you

Zambon's reported carbon emissions

Zambon, headquartered in Italy, currently does not provide specific carbon emissions data or reduction targets. Without available figures on their emissions, it is unclear how they are addressing their carbon footprint. However, the company is likely to be engaged in industry-standard climate commitments, which may include initiatives aimed at reducing greenhouse gas emissions and improving sustainability practices. As the pharmaceutical sector increasingly focuses on climate action, Zambon may be aligning its strategies with broader industry trends, although specific details on their commitments or targets are not disclosed.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Zambon's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Zambon is in IT, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Zambon is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Chiesi Farmaceutici

IT
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

RECORDATI

LU
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Almirall

ES
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Lundbeck

DK
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Menarini

IT
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Esteve Pharmaceuticals, S.A.

ES
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers